1 / 2

Osimertinib Intermediates - Vidgastech

Osimertinib Intermediates refer to the chemical compounds used in the synthesis of Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is primarily used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations, particularly T790M mutation-positive NSCLC.<br><br>Key Aspects of Osimertinib Intermediates:<br>Purpose: They are crucial in the multi-step chemical synthesis of osimertinib.<br>Chemical Structure: Includes aromatic amines, pyrimidine derivatives, and acrylamide-based moieties.<br>Application: Used in pharmaceutical manufacturing

vidgastech
Download Presentation

Osimertinib Intermediates - Vidgastech

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Welcome to VIDGAS Tech Our mission at VIDGAS is to provide our pharmaceutical, Bio pharma, Agrochemical, Food and Fine chemical customers with the highest quality SFC and HPLC purification and isolation solutions that market has to offer. With our 25 years of HPLC experience, we are able to provide variety of products with custom tailored answers for even most difficult separations. Our team of professional Chromatographers is available to assist in HPLC and SFC methods development solutions. Here at VIDGAS we are constantly innovating and pursuing the limits of HPLC and SFC. 3,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-ONE 6-AMINOURACIL ALLOPURINOL INTERMEDIATES API Intermediates ENZALUTAMIDE INTERMEDIATES FEDRATINIB INTERMEDIATES IBRUTINIB INTERMEDIATE IVACAFTOR INTERMEDIATE MOLNUPIRAVIR INTERMEDIATES OLMESARTAN INTERMEDIATES OSIMERTINIB INTERMEDIATES OTHER INTERMEDIATES Palbociclib Intermediates PAZOPANIB INTERMEDIATES PIOGLITAZONE INTERMEDIATES RIPASUDIL INTERMEDIATES RUXOLITINIB INTERMEDIATES TENELIGLIPTIN INTERMEDIATES

  2. TICAGRELOR INTERMEDIATES TOFACITINIB INTERMEDIATES TUCATANIB INTERMEDIATES VILDAGLIPTIN INTERMEDIATES Z-GUGGULSTERONE ZANUBRUTINIB INTERMEDIATES

More Related